Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VANCOUVER and MINNEAPOLIS, MN, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally...
-
Elective Interventional Procedures Resume in Germany VANCOUVER and MINNEAPOLIS, MN, June 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:...
-
Less invasive approach provides hope for the millions of patients that suffer from leaky mitral valves VANCOUVER and MINNEAPOLIS, MN, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
-
Company outlines milestone achievements towards value creation VANCOUVER and MINNEAPOLIS, May 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company")...
-
VANCOUVER and MINNEAPOLIS, May 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
-
Promotes John Panton to Chief Quality Officer VANCOUVER and MINNEAPOLIS, MN, May 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc Inc. ("Neovasc" or the "Company")...
-
VANCOUVER and MINNEAPOLIS, May 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
-
VANCOUVER and MINNEAPOLIS, MN, April 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...
-
VANCOUVER and MINNEAPOLIS, March 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive...
-
VANCOUVER, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement...